Halozyme wins Dutch patent ruling that Merck’s Keytruda SC infringes MDASE patent

 Halozyme wins Dutch patent ruling that Merck’s Keytruda SC infringes MDASE patent EP 2,797,622

• Injunction halts manufacture and sale of Keytruda SC in multiple European markets.
• Halozyme and argenx expand global ENHANZE collaboration and license agreement.
• Expanded ENHANZE deal adds two exclusive targets for argenx.
• Agreement extends milestones and royalty stream under the ENHANZE collaboration.

https://finviz.com/stock?t=HALO&p=d